- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Castration Resistant Prostate Cancer in Colombia
Total 615 results
-
Janssen Research & Development, LLCActive, not recruitingMetastatic Castration-sensitive Prostate CancerUnited States, Italy, China, Korea, Republic of, Canada, Australia, United Kingdom, Hungary, France, Taiwan, Thailand, Germany, Malaysia, Denmark, Russian Federation, New Zealand, Ukraine, Bulgaria, Israel, Spain, Turkey, Sweden, Cz... and more
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Hoffmann-La RocheCompleted
-
SanofiCompleted
-
Achieve Life SciencesTeva Pharmaceuticals USATerminatedHormone Refractory Prostate Cancer | Castrate-Resistant Prostate CancerFrance, United States, Spain, United Kingdom, Canada
-
VA Office of Research and DevelopmentRecruitingMetastatic Castrate Resistant Prostate Cancer | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | RAD51B, RAD51C, RAD51D, or RAD54L MutationsUnited States
-
AmgenCompletedCarcinoma | Cancer | Prostate Cancer | Tumors | Castrate-Resistant Prostate CancerUnited States, Canada, Poland, Hungary, Finland, Mexico
-
US Oncology ResearchPfizerCompleted
-
Christopher Sweeney, MBBSSanofi; Hoosier Cancer Research Network; Walther Cancer InstituteTerminatedMetastatic Prostate CancerUnited States, Canada
-
Eisai Inc.Completed
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
AstraZenecaCompletedNon-metastatic Prostate CancerUnited States, Canada
-
British Columbia Cancer AgencyBC Cancer FoundationRecruitingAdvanced Cancers | Metastatic Cancers | Cancers That Cannot be Treated With Curative IntentCanada
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.; Medivation, Inc.; Biologics...Active, not recruitingRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States, Canada, Puerto Rico
-
Canadian Cancer Trials GroupCanadian Cancer Society (CCS)RecruitingProstate Cancer MetastaticCanada
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticCanada, United States, France, United Kingdom
-
Georgetown UniversityU.S. Army Medical Research and Development CommandCompleted
-
British Columbia Cancer AgencyCanadian Institutes of Health Research (CIHR)Completed
-
NanOlogy, LLCUS Biotest, Inc.TerminatedUrogenital Neoplasms | Genital Neoplasms, Male | Prostate Cancer | Prostate Adenocarcinoma | Prostatic Neoplasm | Localized Cancer | Prostate Cancer AdenocarcinomaUnited States
-
Arvinas Androgen Receptor, Inc.RecruitingProstate Cancer MetastaticUnited States
-
ExelixisTakeda; Roche-GenentechActive, not recruitingMetastatic Prostate Cancer | Prostate AdenocarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Russian Federation, Singapore, Spain, ... and more
-
George Washington UniversityTerminatedProstate AdenocarcinomaUnited States
-
Janssen-Ortho Inc., CanadaCompleted
-
British Columbia Cancer AgencyCompletedHormone Refractory Prostate CancerCanada
-
Hoffmann-La RocheCompletedMetastatic Prostate CancerUnited States, Belgium, France, United Kingdom, Canada, Korea, Republic of, China, Denmark, Greece, Ireland, Portugal, Spain, Italy, Brazil, Mexico, Australia, Thailand, Japan, Costa Rica, Israel, Russian Federation, Austria, Hungary, Norwa... and more
-
Janssen Research & Development, LLCCompletedMetastatic Prostate CancerUnited States, Korea, Republic of, Australia, Poland, Taiwan, France, Thailand, Malaysia, Russian Federation, Canada, Bulgaria, Italy, Spain, Turkey, Sweden, Israel, Belarus, Ukraine, Brazil, Argentina, Belgium, Denmark, United Kingdom and more
-
Alberta Health servicesAmersham Health; The Prostate Cancer Research Foundation of CanadaCompletedBone Metastases | Hormone Refractory Prostate CancerCanada
-
Timothy HoffmanUniversity of Missouri-Columbia; Harry S. Truman Memorial Veterans' Hospital; Telix Pharmaceuticals, LtdTerminatedProstate Cancer | Prostate AdenocarcinomaUnited States
-
Accuray IncorporatedCompletedProstatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone Refractory Prostate CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Novartis Pharmaceuticals; Eastern Cooperative... and other collaboratorsCompletedProstate Cancer | Metastatic CancerUnited States, Canada
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States, Canada
-
National Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Localized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8United States
-
University Health Network, TorontoCompletedProstate Cancer (Adenocarcinoma)Canada
-
Janssen Research & Development, LLCActive, not recruitingProstatic Neoplasms, Castration-ResistantBelgium, United States, United Kingdom, Canada, Israel, Spain, Italy
-
British Columbia Cancer AgencyRecruiting
-
Bavarian NordicCompletedAndrogen-insensitive Prostate CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Georgetown... and other collaboratorsCompletedProstate Cancer | Adenocarcinoma of ProstateUnited States
-
British Columbia Cancer AgencyRecruitingOligometastatic Prostate CancerCanada
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
British Columbia Cancer AgencyCompleted
-
SonaCare MedicalUnknown
-
British Columbia Cancer AgencyBiocompatibles UK LtdCompleted
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); North Central Cancer Treatment GroupCompletedPain | Breast Cancer | Prostate Cancer | Metastatic CancerUnited States, Canada
-
British Columbia Cancer AgencyUniversity of British Columbia; Vancouver Prostate Centre; BC Cancer FoundationRecruitingLocalized Prostate CarcinomaCanada
-
National Human Genome Research Institute (NHGRI)Completed
-
British Columbia Cancer AgencyRecruitingProstate CancerCanada
-
University of Missouri-ColumbiaWithdrawnProstate CancerUnited States